Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019 To 2020

On Auguest 10, 2022, the U.S. Centers for Disease Control and Prevention published this "Vital Signs" report regarding Hepatitis C treatment among insurad adults in the U.S. from 2019 to 2020. This analysis used a large national health care claims  database to assess hepatitis C treatment among persons with diagnosed HCV infection by sex, age, race, insurance type (i.e., private, Medicaid, and Medicare), and by state Medicaid treatment restrictions . . .